Comparison of the 1-Year Visual and Anatomical Outcomes between Subthreshold Red (670 nm) and Yellow (577 nm) Micro-Pulse Laser Treatment for Diabetic Macular Edema

We investigated the efficacy and safety of red (670 nm) subthreshold micropulse laser (SMPL) treatment for diabetic macular edema (DME) and compared the 1-year treatment outcomes of red and yellow (577 nm) SMPL for DME. A medical chart review was performed in 43 consecutive eyes of 35 patients who u...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Wataru Kikushima, Taiyo Shijo, Yukiko Furuhata, Yoichi Sakurada, Kenji Kashiwagi
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	diabetic macular edema subthreshold red micropulse laser treatment subthreshold yellow micropulse laser treatment diabetic retinopathy Medicine R Pharmacy and materia medica RS1-441
Acceso en línea:	https://doaj.org/article/14173d75fad84c418363217301298006
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:14173d75fad84c418363217301298006
record_format	dspace
spelling	oai:doaj.org-article:14173d75fad84c4183632173012980062021-11-25T18:39:20ZComparison of the 1-Year Visual and Anatomical Outcomes between Subthreshold Red (670 nm) and Yellow (577 nm) Micro-Pulse Laser Treatment for Diabetic Macular Edema10.3390/ph141111001424-8247https://doaj.org/article/14173d75fad84c4183632173012980062021-10-01T00:00:00Zhttps://www.mdpi.com/1424-8247/14/11/1100https://doaj.org/toc/1424-8247We investigated the efficacy and safety of red (670 nm) subthreshold micropulse laser (SMPL) treatment for diabetic macular edema (DME) and compared the 1-year treatment outcomes of red and yellow (577 nm) SMPL for DME. A medical chart review was performed in 43 consecutive eyes of 35 patients who underwent red or yellow SMPL treatment for DME and were followed up for 12 months. There were 26 and 17 eyes in the yellow and red SMPL groups, respectively. The mean best-corrected visual acuity (BCVA) was maintained throughout the follow-up period of 12 months in the yellow and red SMPL groups (<i>p</i> = 0.39, <i>p</i> = 0.70, respectively). The central retinal thickness (CRT) measured by spectral-domain optical coherence tomography (SD-OCT) was significantly decreased at 12 months from baseline in the yellow and red SMPL groups (<i>p</i> = 0.047, <i>p</i> = 0.03, respectively). Although the amount of CRT reduction in the red SMPL group was significantly greater than that in the yellow SMPL group at 8 months from baseline (<i>p</i> = 0.02), the significance disappeared at the final follow-up period (<i>p</i> = 0.44). The red SMPL maintained the BCVA in patients with center-involving DME. The mean CRT in the red SMPL group significantly decreased, and the amount of CRT reduction was equivalent to that in the yellow SMPL group.Wataru KikushimaTaiyo ShijoYukiko FuruhataYoichi SakuradaKenji KashiwagiMDPI AGarticlediabetic macular edemasubthreshold red micropulse laser treatmentsubthreshold yellow micropulse laser treatmentdiabetic retinopathyMedicineRPharmacy and materia medicaRS1-441ENPharmaceuticals, Vol 14, Iss 1100, p 1100 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	diabetic macular edema subthreshold red micropulse laser treatment subthreshold yellow micropulse laser treatment diabetic retinopathy Medicine R Pharmacy and materia medica RS1-441
spellingShingle	diabetic macular edema subthreshold red micropulse laser treatment subthreshold yellow micropulse laser treatment diabetic retinopathy Medicine R Pharmacy and materia medica RS1-441 Wataru Kikushima Taiyo Shijo Yukiko Furuhata Yoichi Sakurada Kenji Kashiwagi Comparison of the 1-Year Visual and Anatomical Outcomes between Subthreshold Red (670 nm) and Yellow (577 nm) Micro-Pulse Laser Treatment for Diabetic Macular Edema
description	We investigated the efficacy and safety of red (670 nm) subthreshold micropulse laser (SMPL) treatment for diabetic macular edema (DME) and compared the 1-year treatment outcomes of red and yellow (577 nm) SMPL for DME. A medical chart review was performed in 43 consecutive eyes of 35 patients who underwent red or yellow SMPL treatment for DME and were followed up for 12 months. There were 26 and 17 eyes in the yellow and red SMPL groups, respectively. The mean best-corrected visual acuity (BCVA) was maintained throughout the follow-up period of 12 months in the yellow and red SMPL groups (<i>p</i> = 0.39, <i>p</i> = 0.70, respectively). The central retinal thickness (CRT) measured by spectral-domain optical coherence tomography (SD-OCT) was significantly decreased at 12 months from baseline in the yellow and red SMPL groups (<i>p</i> = 0.047, <i>p</i> = 0.03, respectively). Although the amount of CRT reduction in the red SMPL group was significantly greater than that in the yellow SMPL group at 8 months from baseline (<i>p</i> = 0.02), the significance disappeared at the final follow-up period (<i>p</i> = 0.44). The red SMPL maintained the BCVA in patients with center-involving DME. The mean CRT in the red SMPL group significantly decreased, and the amount of CRT reduction was equivalent to that in the yellow SMPL group.
format	article
author	Wataru Kikushima Taiyo Shijo Yukiko Furuhata Yoichi Sakurada Kenji Kashiwagi
author_facet	Wataru Kikushima Taiyo Shijo Yukiko Furuhata Yoichi Sakurada Kenji Kashiwagi
author_sort	Wataru Kikushima
title	Comparison of the 1-Year Visual and Anatomical Outcomes between Subthreshold Red (670 nm) and Yellow (577 nm) Micro-Pulse Laser Treatment for Diabetic Macular Edema
title_short	Comparison of the 1-Year Visual and Anatomical Outcomes between Subthreshold Red (670 nm) and Yellow (577 nm) Micro-Pulse Laser Treatment for Diabetic Macular Edema
title_full	Comparison of the 1-Year Visual and Anatomical Outcomes between Subthreshold Red (670 nm) and Yellow (577 nm) Micro-Pulse Laser Treatment for Diabetic Macular Edema
title_fullStr	Comparison of the 1-Year Visual and Anatomical Outcomes between Subthreshold Red (670 nm) and Yellow (577 nm) Micro-Pulse Laser Treatment for Diabetic Macular Edema
title_full_unstemmed	Comparison of the 1-Year Visual and Anatomical Outcomes between Subthreshold Red (670 nm) and Yellow (577 nm) Micro-Pulse Laser Treatment for Diabetic Macular Edema
title_sort	comparison of the 1-year visual and anatomical outcomes between subthreshold red (670 nm) and yellow (577 nm) micro-pulse laser treatment for diabetic macular edema
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/14173d75fad84c418363217301298006
work_keys_str_mv	AT watarukikushima comparisonofthe1yearvisualandanatomicaloutcomesbetweensubthresholdred670nmandyellow577nmmicropulselasertreatmentfordiabeticmacularedema AT taiyoshijo comparisonofthe1yearvisualandanatomicaloutcomesbetweensubthresholdred670nmandyellow577nmmicropulselasertreatmentfordiabeticmacularedema AT yukikofuruhata comparisonofthe1yearvisualandanatomicaloutcomesbetweensubthresholdred670nmandyellow577nmmicropulselasertreatmentfordiabeticmacularedema AT yoichisakurada comparisonofthe1yearvisualandanatomicaloutcomesbetweensubthresholdred670nmandyellow577nmmicropulselasertreatmentfordiabeticmacularedema AT kenjikashiwagi comparisonofthe1yearvisualandanatomicaloutcomesbetweensubthresholdred670nmandyellow577nmmicropulselasertreatmentfordiabeticmacularedema
_version_	1718410816734101504

Comparison of the 1-Year Visual and Anatomical Outcomes between Subthreshold Red (670 nm) and Yellow (577 nm) Micro-Pulse Laser Treatment for Diabetic Macular Edema

Ejemplares similares